Hypolipidemic Activity of 4-Phenyl-5,5-Dicarbethoxy-2-Pyrrolidinone in Rodents

Add time:07/16/2019    Source:sciencedirect.com

A series of pyrrolidinones have been reported to possess hypoli-pidemic activity in mice. The most active agent, 4-phenyl-5-5-dicarbethoxy-2-pyrrolidinone, effectively lowered both serum cholesterol and triglyceride levels at 20–30 mg/kg/d. The agent suppressed liver mitochondrial citrate exchange, phosphatidate phosphohydrolase, andsn-glycerol-3-phosphate acyl transferase activities. Lipid content of the liver, small intestine, and serum lipoprotein fractions was reduced by drug treatment, but lipid levels increased in the bile and fecal samples, suggesting the drug accelerated lipid excretion. The mode of action of the pyrrolidinone appears similar to that of the cyclic imides.

We also recommend Trading Suppliers and Manufacturers of 4-Phenyl-2-pyrrolidinone (cas 1198-97-6). Pls Click Website Link as below: cas 1198-97-6 suppliers

Prev:Fabrication of an efficient and sensitive colorimetric biosensor based on Uricase/ Th-MOF for uric acid sensing in biological samples
Next:2-(2-Ethynyl-1-aziranyl)-3,4-dihydro-2H-pyrrole: a one-pot assembly from isopropyl phenyl ketoxime and acetylene during the synthesis of 3H-pyrrole)